Eastman Chemical Company
EMNBasic MaterialsNASDAQSpecialty Chemicals
Scan Results
Daily timeframePart of the basic materials sector, Eastman Chemical Company (EMN) is listed under Specialty Chemicals. With a market capitalization of $7.42B, it sits in mid-cap territory. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.
Market Cap
$7.42B
Beta
1.08
P/E (TTM)
16.95
P/E (Fwd)
9.78
EPS (TTM)
$3.83
EPS (Fwd)
$6.64
ROE
7.3%
ROA
3.5%
Cash
$693.0M
Total Debt
$5.47B
Free CF
$544.6M
52W Change
1.8%
Annual Financials
Cash vs Debt
Where EMN stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, EMN finished 10.18% below its 150-day moving average ($69.56) and 10.28% below its 200-day moving average ($69.64). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is EMN overbought or oversold?
At the October 20, 2026 close, EMN's RSI(14) was 33.9, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Eastman Chemical Company carries $5.47B in total debt against $693.0M in cash reserves — debt is roughly 7.9x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $544.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 7.3% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.5% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $10.58B (2022) to $8.75B (2025), a 17% decline worth watching.
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing EMN.